Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jaume Pons Insider Profile
11 Followers
Jaume Pons, PRESIDENT & CSO at ALX Oncology Holdings, holds 591.51K shares in ALX Oncology Holdings (Ticker: ALXO). Most recently, Jaume Pons Sold $1,937 shares of ALX Oncology Holdings on Aug 16, 2024 for an estimated value of 5.00K.
Jaume Pons ALX Oncology Holdings (ALXO)PRESIDENT & CSO
ALX Oncology Holdings (ALXO)
PRESIDENT & CSO
Ranked #25,765 out of 98,384 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+12.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
PRESIDENT & CSO
Roles that Jaume Pons holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jaume Pons
Jaume Pons's Trading History
List of latest transactions for each holding click on a transaction to see Jaume Pons's performance on stock
You May Also Like
Jaume Pons insider profile FAQ
What is the percentage of profitable transactions made by Jaume Pons?
The percentage of profitable transactions made by Jaume Pons is 50%.
What is the average return per transaction made by Jaume Pons?
The average return per transaction made by Jaume Pons is 12.80%.
What stocks does Jaume Pons hold?
Jaume Pons holds: ALXO stocks.
What was Jaume Pons’s latest transaction?
Jaume Pons latest transaction was an Informative Sell of $5.00K.
What was Jaume Pons's most profitable transaction?
Jaume Pons’s most profitable transaction was an Informative Sell of ALXO stock on July 3, 2024. The return on the trade was 54.60%.
What is Jaume Pons's role in ALX Oncology Holdings?
Jaume Pons's role in ALX Oncology Holdings is PRESIDENT & CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.